Prosecution Insights
Last updated: May 29, 2026
Application No. 17/758,670

VASCULAR TREATMENT DEVICES, SYSTEMS, AND METHODS OF USE

Final Rejection §102§103
Filed
Jul 12, 2022
Priority
Feb 13, 2020 — provisional 62/976,342 +1 more
Examiner
RODJOM, KATHERINE MARIE
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
The Foundry LLC
OA Round
2 (Final)
66%
Grant Probability
Favorable
3-4
OA Rounds
5m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allowance Rate
435 granted / 661 resolved
-4.2% vs TC avg
Strong +34% interview lift
Without
With
+33.9%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
23 currently pending
Career history
688
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
80.2%
+40.2% vs TC avg
§102
13.0%
-27.0% vs TC avg
§112
2.2%
-37.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 661 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The amendment filed December 15, 2025 has been entered. Claims 1-20 are currently pending. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim(s) 1-14 is/are rejected under 35 U.S.C. 103 as being unpatentable over Thornton (US 5,573,508, hereinafter “Thornton”) in view of Krolik et al. (US 2010/0036410, hereinafter “Krolik”). Regarding claim 1, Thornton discloses the invention substantially as claimed, including a system for treating a blood flow passage of a patient (Figs 1-3, 8-9), the system comprising: a treatment element comprising: an expandable element (balloon 17) configured to be positioned within the passage, the expandable element having a collapsed configuration and an expanded configuration in which the expandable element defines a lumen therethrough (col 4, ln 58-67), and a reinforcing element (60) positioned within the lumen of the expandable element, the reinforcing element having a collapsed configuration and an expanded configuration in which the reinforcing element defines a lumen therethrough (col 7, ln 37-58); a pushing element (62) comprising a proximal end portion and a distal end portion, wherein the distal end portion is configured to engage a proximal end portion of the reinforcing element such that distal movement of the pushing element causes the reinforcing element to radially expand (col 7, ln 37-58); a first elongated member (15) defining a first lumen therethrough, the first lumen (16) in fluid communication with an interior region of the expandable element, wherein the first elongated member is configured to deliver a fluid to the interior region of the expandable element to expand the expandable element (col 4, ln 58-67); a second elongated member (65) defining a second lumen therethrough, wherein a distal portion of the second elongated member is coupled to a distal portion of the reinforcing element (col 7, ln 37-58), wherein the second elongated member extends through the lumen of the expandable element (17) (col 2, ln 27-33 – “Means are provided to expand the perfusion lumen particularly the portion extending with the balloon on the distal end of the catheter shaft”; col 6, ln 19-24 – when describing the alternate embodiment of Figs 1-3: “The coil 25 should be long enough to expand at least a significant portion of the perfusion lumen 13 and is preferably long enough to extend from a location proximal to the proximal perfusion ports to a location near the distal end of the balloon e.g. about 10 to about 40 cm in length.”). However, Thornton fails to disclose a third elongated member defining a third lumen therethrough, the third lumen configured to receive the first and second elongated members and the pushing element therein. Krolik discloses a similar system for treating a blood flow passage of a patient and teaches the treatment element comprising an expandable element and inner reinforcing element may further comprise one or more introducer sheaths or other tubular body to guide the device to the target area within the blood vessel (para [0081]). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Thornton such that the system further included a third elongate member in the form of an introducer sheath, as taught by Krolik, wherein the introducer sheath defines a third lumen configured to receive the first and second elongated members and the pushing element therein to assist in guiding the device to the target area of the vasculature. Regarding claim 2, wherein distal movement of the pushing element (62) causes distal movement of the proximal end portion of the reinforcing element (60) (Figs 8-9; relative movement between members 62 and 63 causes expansion/contraction of reinforcing element 60 – col 7, ln 37-58). Regarding claim 3, wherein the distal end portion of the pushing element (62) is configured to substantially abut the proximal end portion of the reinforcing element (60) (Figs 8-9; col 7, ln 37-58). Regarding claim 4, wherein, distal movement of the proximal end portion of the reinforcement element (60) causes the reinforcing element to axially compress and radially expand (Figs 8-9; relative movement between members 62 and 63 causes expansion/contraction of reinforcing element 60 – col 7, ln 37-58). Regarding claim 5, wherein the pushing element (62) is configured to apply a distally directed force to the proximal end portion of the reinforcing element (60) (Figs 8-9; relative movement between members 62 and 63 causes expansion/contraction of reinforcing element 60 – col 7, ln 37-58). Regarding claim 6, wherein the distal end portion of the pushing element (62) has a tubular shape (Figs 8-9; col 7, ln 37-58). Regarding claim 7, Thornton teaches the “system is applicable for over-the-wire and rapid exchange type catheters” (col 2, ln 47-48). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to further modify the combination of Thornton and Krolik, such that the system was designed for rapid exchange and the pushing element exited the third lumen through an opening in a sidewall of the third elongated member. Thus, the system may be more easily exchanged with the guide wire in a rapid exchange manner as is old and well known in the art. Regarding claim 8, wherein the reinforcing element (60) is configured to contact an inner wall of the expandable element (17). Regarding claim 9, wherein the distal portion of the second elongated member (65) is coupled to the distal portion of the reinforcing element (60) via a coupler (adhesive or other securing means – col 6, ln 54-55). Regarding claim 10, further comprising a stopper (integrally connected to proximal end portion of second elongate member 65) configured to limit axial translation of the pushing element (62) and/or axial compression of the reinforcing element (60) (Figs 8-9). Regarding claim 11, further comprising a stopper (integrally connected to proximal end portion of second elongate member 65) configured to limit axial translation of the pushing element (62) and/or axial compression of the reinforcing element (60) (Figs 8-9), wherein the stopper is positioned proximal of the coupler (adhesive or other securing means). Regarding claim 12, wherein a distal end portion of the stopper is secured to the coupler (stopper integrally connected to proximal end portion of second elongate member 65). Regarding claim 13, wherein a proximal end portion of the stopper is secured to the pushing element (secured through reinforcing element 60). Regarding claim 14, Thornton teaches the expandable element (balloon 17) may be secured by bonding or any suitable means (col 6, ln 50-59). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to further modify the combination such that the expandable element was secured to the second elongated member and/or the third elongated member by a tether as a person with ordinary skill has good reason to pursue the known options within his or her technical grasp and since it is obvious to choose from a finite number of identified, predictable solutions with a reasonable expectation of success. Allowable Subject Matter Claims 15-20 are allowed. The following is an examiner’s statement of reasons for allowance: Of the closest prior art, Thornton fails to teach or disclose the intermediate portion of the second elongate member is continuous and extends between the proximal and distal shoulders as amended. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Response to Arguments Applicant's arguments filed December 15, 2025, regarding the rejection of claims 1-14 under 35 U.S.C. 103 as being unpatentable over Thornton (US 5,573,508) in view of Krolik (US 2010/0036410), have been fully considered but they are not persuasive. Applicant argues Thornton fails to disclose “wherein the second elongated member extends through the lumen of the expandable element”. Applicant argues Thornton fails to teach the alternative embodiment of the expanding means 23 shown in Figs 8 and 9 of Thornton, including the second elongated member (or distal collar 65), does not extend through the lumen of the balloon (17). The Examiner respectfully disagrees. Applicant points to Fig 1 of Thornton for evidence the expandable means does not extend through the balloon; however, a second position of Fig 3 clearly shows the expandable means extending through the balloon. Furthermore, Thornton teaches “Means are provided to expand the perfusion lumen particularly the portion extending with the balloon on the distal end of the catheter shaft” (col 2, ln 27-33). Applicant’s arguments, see amendment, filed December 15, 2025, with respect to the rejection of claims 15-19 under 35 USC 102(a)(1) as being anticipated by Thornton (US 5,573,508) have been fully considered and are persuasive. Thornton fails to teach or disclose the intermediate portion of the second elongate member is continuous and extends between the proximal and distal shoulders as amended. The rejection has been withdrawn. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATHERINE MARIE RODJOM whose telephone number is (571)272-3201. The examiner can normally be reached Monday - Thursday 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at 571-272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KATHERINE M RODJOM/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jul 12, 2022
Application Filed
Jul 30, 2025
Non-Final Rejection mailed — §102, §103
Oct 09, 2025
Applicant Interview (Telephonic)
Oct 09, 2025
Examiner Interview Summary
Dec 15, 2025
Response Filed
Apr 01, 2026
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12629167
Surgical Tool Arrangement And Surgical Cutting Accessory For Use Therewith
3y 3m to grant Granted May 19, 2026
Patent 12582439
TRANSCAROTID VASCULAR ACCESS SHEATH
5y 9m to grant Granted Mar 24, 2026
Patent 12575844
SYSTEM, DEVICES AND METHODS FOR REMOVING OBSTRUCTIONS IN BODY LUMENS
9m to grant Granted Mar 17, 2026
Patent 12551326
RETRIEVAL CATHETER
2y 12m to grant Granted Feb 17, 2026
Patent 12502510
Torque Device Apparatus and Method of Use
3y 0m to grant Granted Dec 23, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
66%
Grant Probability
99%
With Interview (+33.9%)
4y 3m (~5m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 661 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month